Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply: Pulse Pressure and Cardiovascular Death.
Selvaraj S, Steg PG, Elbez Y, Sorbets E, Feldman LJ, Eagle KA, Ohman EM, Blacher J, Bhatt DL. Selvaraj S, et al. Among authors: eagle ka. J Am Coll Cardiol. 2016 Jul 5;68(1):132-3. doi: 10.1016/j.jacc.2016.04.020. J Am Coll Cardiol. 2016. PMID: 27364059 Free article. No abstract available.
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Cannon CP, Rhee KE, Califf RM, Boden WE, Hirsch AT, Alberts MJ, Cable G, Shao M, Ohman EM, Steg PG, Eagle KA, Bhatt DL; REACH Registry Investigators. Cannon CP, et al. Among authors: eagle ka. Am J Cardiol. 2010 Feb 15;105(4):445-52. doi: 10.1016/j.amjcard.2009.10.014. Epub 2010 Jan 5. Am J Cardiol. 2010. PMID: 20152237
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL; REACH Registry Investigators. Kumbhani DJ, et al. Among authors: eagle ka. Eur Heart J. 2014 Nov 1;35(41):2864-72. doi: 10.1093/eurheartj/ehu080. Epub 2014 Feb 28. Eur Heart J. 2014. PMID: 24585266 Free PMC article.
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry.
Picard F, Bhatt DL, Ducrocq G, Ohman EM, Goto S, Eagle KA, Wilson PWF, Smith SC Jr, Elbez Y, Steg PG. Picard F, et al. Among authors: eagle ka. Int J Cardiol. 2021 Oct 1;340:96-104. doi: 10.1016/j.ijcard.2021.08.031. Epub 2021 Aug 25. Int J Cardiol. 2021. PMID: 34450192 Clinical Trial.
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA, Hoffman E, Bhatt DL; REACH Registry Investigators. Rodriguez F, et al. Among authors: eagle ka. Clin Cardiol. 2013 Dec;36(12):721-7. doi: 10.1002/clc.22217. Epub 2013 Oct 25. Clin Cardiol. 2013. PMID: 24166484 Free PMC article.
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
Udell JA, Steg PG, Scirica BM, Eagle KA, Ohman EM, Goto S, Alsheikh-Ali AA, Porath A, Corbalan R, Umez-Eronini AA, Hoffman EB, Wilson PW, Bhatt DL; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Udell JA, et al. Among authors: eagle ka. Eur J Prev Cardiol. 2014 Dec;21(12):1531-40. doi: 10.1177/2047487313500541. Epub 2013 Aug 5. Eur J Prev Cardiol. 2014. PMID: 23918840
716 results